The emerging NDM carbapenemases.

By P. Nordmann, L. Poirel, T. Walsh, D. Livermore. Trends in Microbiology, 2011

648 citations recorded by the source corpus.

Subfields: Endocrinology, Molecular Medicine, Pharmacology

View Paper: https://www.semanticscholar.org/paper/a0a339a026f0fd4a32881db33d2890ea8f4c5171

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology

1. P. Nordmann
2. L. Poirel
3. J. Pitout
4. G. Meletis
5. Jung Hun Lee
6. Chang-Ro Lee
7. B. Jeong
8. S. Lee

In Molecular Medicine

1. L. Poirel
2. P. Nordmann
3. J. Pitout
4. G. Meletis
5. Gerard D. Wright
6. Jung Hun Lee
7. Chang-Ro Lee
8. B. Jeong

In Pharmacology

1. Gerard D. Wright
2. P. Nordmann
3. L. Poirel
4. C. Arias
5. J. Munita
6. J. Pitout
7. Kirandeep Bhullar
8. Andrew C. Pawlowski

Citations in the corpus

• Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods (2016, background): “Various class B and D carbapenemases have also been detected in hospital-acquired multi-resistant K. pneumoniae (Nordmann et al., 2011a), whereas class C carbapenemases have rarely been reported.”
• Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. (2015, background): “The risk of infection is particularly high in individuals in association with prolonged hospitalization, catheterization, nursing home residency, previous antibiotic treatment, underlying renal or liver pathology, and travel to high-risk areas (Nordmann et al., 2011).”
• The Comprehensive Antibiotic Resistance Database (2013, background): “, and Vibrio cholerae since its initial discovery in Klebsiella pneumoniae and Escherichia coli in 2008 (21).”
• Carbapenem resistance: overview of the problem and future perspectives (2016, background): “NDM-producing microorganisms have been isolated with high frequency in healthcare facilities and environmental niches in the Indian subcontinent and disseminated through patient transfer or colonized travellers in Europe, North America, the Far East and Australia [Dortet et al. 2014].”
• The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae (2015, background): “Since high risk clones and epidemic plasmids do not seem to play important roles in the global dissemination of NDMs, we refer the readers to some excellent review articles and recent reports on this topic (11, 33-36).”
• Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance (2015, background): “, third- and fourth-generation) cephalosporins may be effective against OXA-48 producers without ESBLs (128), while aztreonam remains an option for treating infections due to MBL producers that test susceptible to this agent (37).”
• Mechanisms of Antibiotic Resistance (2016, result): “In contrast to other genes encoding metallo-enzymes, bla NDM is not usually related to integron-like structures (30).”
• The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. (2014, background): “being from a Swedish patient of Indian origin hospitalized in Örebro, Sweden, after a hospital stay in New Delhi [62,63].”